Top Markets
Coin of the day
Creso Pharma Limited Creso Pharma Limited

Creso Pharma Limited

CPH
Classement en actions #30562
Creso Pharma Ltd. specializes in the development, registration, and... Creso Pharma Ltd. specializes in the development, registration, and commercialization of high-quality, pharmaceutical-grade cannabis and hemp-derived nutraceuticals. These health solutions are designed for both human and animal wellness, distributed across Europe, the Middle East, North America, and the Asia Pacific. The company also undertakes the creation and sale of therapeutic products, in addition to cultivating, processing, and supplying cannabis products to retail markets. Among its diverse product line are "anibidiol," a complementary feed for companion animals; "cannaQIX," a nutraceutical containing hemp oil extract, vitamins, and zinc, formulated to reduce stress and support psychological and nervous system functions; and topical skincare items like "cannaDOL," a CBD-based gel featuring a blend of cooling and warming essential oils. Creso Pharma Limited was founded in 2015 and operates from its headquarters in Nedlands, Australia.
Prix de l'action
$0.00634756
Dernière synchronisation: 2023-06-09
Capitalisation boursière
$16.30M
Changement (1 jour)
5.01%
Changement (1 an)
0.00%
Pays
AU
Échange Creso Pharma Limited (CPH)

Catégorie

Ratio P/B pour Creso Pharma Limited (CPH)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Creso Pharma Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Creso Pharma Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes